XOMA Royalty (XOMA) Share-based Compensation Growth (1y) (2011 - 2026)
XOMA Royalty (XOMA) Share-based Compensation Growth (1y) (2011 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Stock Comp. Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
- |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
-69.95% |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
0.18% |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
- |
| 10 |
XOMA Royalty |
5.52 Mn |
-60.56 Mn |
- |
15.03% |
| Date | Value |
|---|
| Mar 31, 2026 |
15.03% |
| Dec 31, 2025 |
79.92% |
| Sep 30, 2025 |
-31.66% |
| Jun 30, 2025 |
-96.28% |
| Mar 31, 2025 |
-30.57% |
| Dec 31, 2024 |
-17.86% |
| Sep 30, 2024 |
-4.67% |
| Jun 30, 2024 |
24.36% |
| Mar 31, 2024 |
81.91% |
| Dec 31, 2023 |
168.12% |
| Sep 30, 2023 |
237.10% |
| Jun 30, 2023 |
158.42% |
| Mar 31, 2023 |
60.53% |
| Dec 31, 2022 |
-43.54% |
| Sep 30, 2022 |
3.47% |
| Jun 30, 2022 |
8.98% |
| Mar 31, 2022 |
-66.25% |
| Dec 31, 2021 |
152.89% |
| Sep 30, 2021 |
10.03% |
| Jun 30, 2021 |
-0.65% |
